Loading...
Home 2017-11-15T16:13:24+00:00

Initiatives

Our T1D cohorts offer a collective voice of more than 50,000 people who seek to inform product development, drive better clinical care, and contribute
to scientific discoveries that can lead to important breakthroughs.

T1D Exchange Quality Improvement initiative is working to transform clinical care for people living with diabetes and support their invidualizeds path to better outcomes.

To support Collaborative Science, T1D Exchange has built a world-class Biobank which contains thousands of biological specimens with corresponding
patient data to help better understand causes of type 1 diabetes, its complications and responses to therapy.

T1D Exchange seeks to discover, support and advance promising solutions for people living with T1D, while reducing risks of bringing these innovations to market.

RESEARCH + STUDIES

Major Study Confirms Racial Disparities Related to Key Diabetes Indicator, Hemoglobin A1c

Standard Test for Determining Blood Sugar Control in People with Diabetes Is Not Always an Accurate Measure of Blood Sugar Control and Interpretation Differs Based on Race. Boston, MA – June 14, 2017 – [...]

T1D Exchange’s Biobank Samples Help Researchers Discover Potential Breakthrough in Understanding and Potentially Treating Diabetic Kidney Disease

Findings shed new light on potential prevention of diabetic kidney and heart disease in patients with type 1 diabetes Men with type 1 diabetes and albuminuria have greater copeptin concentrations than men with normoalbuminuria, [...]

Clinical Study Confirms Continuous Glucose Monitoring is as Safe and Effective as Blood Glucose Monitoring

Data from T1D Exchange Are Supportive of FDA’s Approval for New Indication for Dexcom G5® Mobile Continuous Glucose Monitoring System  Boston, MA – T1D Exchange, a nonprofit organization accelerating research to improve outcomes in type [...]

NEWS

Endocrinologist and Researcher Dr. Dara P. Schuster Named CEO of T1D Exchange

Dr. Schuster comes to T1D Exchange from Eli Lilly and Company, where she launched the company’s diabetes real-world evidence partnership development program. Press Release Boston, MA – June 22, 2018– T1D Exchange, a patient-centered research organization [...]

Innovators From 17 Countries Vie for $250,000 in Prizes Advancing Diabetes Care In the 2018 Diabetes Innovation Challenge

Submissions include research to develop new insulin delivery technologies, therapeutics, diagnostics, and digital app-based tools to improve outcomes Boston, MA – March 20, 2018 – T1D Exchange, a nonprofit research and collaboration organization dedicated to [...]

T1D Exchange Officially Opens the 2018 Diabetes Innovation Challenge Call for Applications

Global Challenge Launched to Identify, Present and Award the Next Breakthrough Solutions for Diabetes Care Boston, MA—November 28, 2017—T1D Exchange, a Boston-based nonprofit organization dedicated to accelerating therapies and improving care in type 1 diabetes, [...]

MEMBERS